News Parexel partners with JFCR for cancer research Parexel and JFCR join forces to fast-track oncology clinical trials in Japan, offering increased opportunities for patient participation.
News Cancer Mortality Rates in India: A Study A study on cancer mortality trends in India from 2000 to 2019 reveals a slight increase in combined sexes but varying trends among different cancers.
News COVID-19 Vaccines Reduce Hospitalizations and Deaths in Cancer Patients Cancer patients saw significant reductions in COVID-19 hospitalizations and deaths due to vaccines, according to a panoramic study. Age played a major role in predicting death rates.
News MSP008-22: A Potential Breakthrough in Treating Cancers Promising progress! Sathgen Therapeutics doses MSP008-22, targeting difficult cancers like TNBC and prostate cancer with no adverse events in the first cohort.
News Mannose: The Sweet Solution to Tackling Cancer Fresh research reveals mannose's potent anti-cancer effects, offering a new approach to cancer treatment. Glycosylation may hold the key to unlocking its full potential.
News A Study Suggests Repurposing Existing Cancer Drugs for Aggressive Cancers NTU Singapore researchers discover potential in repurposing cancer drug ponatinib to target aggressive osteosarcomas and glioblastomas, promising improved treatments for ALT cancers.
News Beating Cancer by 2030: COST Connect's Journey in Cancer Research Diverse expertise at one table sparks remarkable ideas. Discover how COST Connect fosters collaborations for groundbreaking cancer research.
News Groundbreaking Achievement in 3D Bioprinting for Cancer Cell Elimination Revolutionary 3D bioprinting technology harnesses immune cells to combat cancer effectively. A groundbreaking achievement in cancer treatment.
News Next Gen Sequencing to be a Game Changer in Cancer Diagnosis and Cure Next Generation Sequencing (NGS) revolutionizes cancer diagnosis and treatment, saving lives and reducing costs. Experts emphasize targeted therapies and precision medicine for improved patient outcomes.
News Liquid Biopsy in Clinical Oncology can Revolutionize Cancer Diagnosis Liquid biopsy, a non-invasive genomic test, revolutionizes cancer diagnosis and treatment. Detecting tumor DNA in the blood, it offers early detection, personalized treatment plans, and monitoring of cancer progression.